Atlas Trials

Combined PD-1 and CCR5 Inhibition for the Treatment of Refractory Microsatellite Stable mCRC

Clinical trial NCT03274804 · COMPLETED

Trial details

NCT number
NCT03274804
Sponsor
University Hospital Heidelberg
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Colorectal CancerMSS
Start date
2018-04-01
Primary completion
2020-03-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.